CanSino Biologics (CASBF) Stock Price, News & Analysis

Company Overview

CanSino Biologics is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines. Founded in 2009 and headquartered in Tianjin, the company develops vaccines for infectious diseases using several technology platforms, including viral-vector and conjugate technologies.

Its products include Convidecia, an adenovirus-based COVID-19 vaccine, as well as vaccines targeting meningococcal disease. CanSino also conducts research on candidates for diseases such as tuberculosis and other infectious illnesses.

The company primarily serves the Chinese market and has pursued regulatory approvals and partnerships to expand access to its vaccines internationally. Its work spans early-stage research through large-scale vaccine production.

Key Stats

• Today's Range: C$3.41 to C$3.41
• 50-Day Range: C$2.95 to C$4.90
• 52-Week Range: C$2.60 to C$5.00
• Volume: N/A
• Average Volume: 686 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CASBF
• CIK: N/A
• Web: www.cansinotech.com
• Phone: 400-922-2099
• Fax: N/A
• Employees: 1,134
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A